Ferguson Wellman Capital Management’s Novo Nordisk NVO Stock Holding History

Ferguson Wellman Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-189,720	Closed	-$6.63M	–	376
2020 Q4	$6.63M	Sell	189,720 -184,200	-49%	-$6.37M	0.16%	118
2020 Q3	$13M	Buy	373,920 +2,960	+0.8%	+$98.7K	0.36%	74
2020 Q2	$12.1M	Buy	370,960 +7,986	+2%	+$255K	0.37%	69
2020 Q1	$10.9M	Buy	362,974 +6,600	+2%	+$197K	0.41%	65
2019 Q4	$10.3M	Sell	356,374 -7,886	-2%	-$218K	0.3%	87
2019 Q3	$9.42M	Buy	364,260 +13,328	+4%	+$337K	0.3%	90
2019 Q2	$8.96M	Buy	350,932 +158	+0%	+$3.9K	0.3%	91
2019 Q1	$9.17M	Buy	350,774 +14,000	+4%	+$344K	0.31%	87
2018 Q4	$7.76M	Buy	336,774 +13,740	+4%	+$305K	0.3%	88
2018 Q3	$7.61M	Buy	+323,034	New	+$7.88M	0.25%	98

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ferguson Wellman Capital Management's NVO Position: Q1 2021 in Review

Ferguson Wellman Capital Management sold out of Novo Nordisk (NVO) in Q1 2021, closing a stake of 189,720 shares — an estimated $6.63M sold.

Ferguson Wellman Capital Management first reported a position in NVO in Q3 2018 and held it in 10 quarters. The position peaked at $13M in Q3 2020. 707 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

Ferguson Wellman Capital Management reported no remaining Novo Nordisk position as of Q1 2021 after selling out during the quarter.
Ferguson Wellman Capital Management sold 189,720 Novo Nordisk shares in Q1 2021, an estimated $6.63M.
Ferguson Wellman Capital Management first reported a position in Novo Nordisk in Q3 2018 and held it in 10 quarters.
Ferguson Wellman Capital Management's Novo Nordisk position peaked at $13M in Q3 2020.
707 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on Ferguson Wellman Capital Management's 13F filing for Q1 2021, filed 26 Apr 2021.